Bacteria navigate on surfaces using a 'sense of touch'
(Press-News.org) Many disease-causing bacteria such as Pseudomonas aeruginosa crawl on surfaces through a walk-like motility known as "twitching". Nanometers-wide filaments called type IV pili are known to power twitching, but scientists ignore which sensory signals coordinate the microbes' movements.
Now, EPFL researchers have found that Pseudomonas bacteria use a mechanism similar to our sense of touch to navigate on surfaces. "This study changes the way we think about motility in bacteria," says senior author Alexandre Persat, a tenure track assistant professor at EPFL's School of Life Sciences.
Scientists have known that cells from humans and other animals can direct themselves in the direction of stiffer or looser surfaces, but it was unclear whether bacteria could also guide their movement based on mechanical force, Persat says. That's because most studies have focused on identifying mechanisms that guide bacteria to swim towards chemicals such as food, a phenomenon known as chemotaxis.
Research in the Persat lab has instead focused on how bacteria sense and respond to mechanical forces. Previous studies showed that Pseudomonas' pilus works like a harpoon: after it extends and touches a surface, the pilus activates a molecular motor that retracts the filament, thus propelling the cell forward.
To understand what coordinates the pili motors, researchers in the Persat group and their collaborators at the University of California, San Francisco, looked at how individual Pseudomonas bacteria move on surfaces such as the bottom of a laboratory dish. The team suspected that a network of proteins called Chp system regulates twitching, so they analyzed bacteria that lacked different components of the Chp system. Some of these mutant bacteria could barely move as they kept twitching back and forth; others always moved forward, even when they bumped into an obstacle.
By combining fluorescent tags with a microscopy technique that helps to look at single pili in living cells, the researchers found that one messenger protein activates the pili to extend, propelling the cell forward, whereas another protein inhibits the formation of pili at the front of the moving cell. The two opposing messengers aren't found in the same place within the cell. "The activator localizes to the front, where the cell feels the surface with its pili, while the inhibitor localizes everywhere else," says study co-first author Marco Ku?hn.
When bacteria bump into an obstacle such as another cell, the inhibitor allows them to stop and change direction, the researchers found. "This helps the cells navigate based on what they feel in front of them -- like a blind person using a white cane," Persat says. The ability to sense the surrounding environment is useful when bacteria move as a group, he adds, as it helps the microbes to all crawl forward in the same direction.
The findings, published in PNAS, shed light on how bacteria move and could have important implications for human health. Pseudomonas aeruginosa, an opportunistic pathogen that is commonly found in soil, is a leading cause of hospital-acquired infections. Aggregates of Pseudomonas bacteria typically form on surfaces such as catheters and respirators and can be extremely resistant to disinfectants and antimicrobial drugs.
What's more, past research from the Persat group showed that Pseudomonas uses its pili to regulate the secretion of toxins. For this reason, understanding more about the microbes' "sense of touch" could help to develop new therapeutic strategies, Persat says.
Next, the researchers aim to uncover how the bacteria convert a mechanical stimulus into a cellular response, says study co-first author Lorenzo Talà. "We would like to understand the molecular mechanism behind the [bacteria's] sense of touch," he says.
ELSE PRESS RELEASES FROM THIS DATE:
Oncotarget published "Role for Fgr and Numb in retinoic acid-induced differentiation and G0 arrest of non-APL AML cells" which reported that retinoic acid is a fundamental regulator of cell cycle and cell differentiation.
Using a leukemic patient-derived in vitro model of a non-APL AML, these authors previously found that RA evokes activation of a macromolecular signaling complex, a signalosome, built of numerous MAPK-pathway-related signaling molecules; and this signaling enabled Retinoic-Acid-Response-Elements to regulate gene expression that results in cell differentiation/cell cycle arrest. Toward mechanistic ...
Researchers from George Mason University, University of Manitoba, Colorado State University, and Georgetown University published a new paper in the Journal of Marketing that examines an unintended customer consequence of lobbying, decreased customer satisfaction, and also explains marketing-focused efforts that can help prevent it.
The study, forthcoming in the the Journal of Marketing, is titled "Shedding Light on the Dark Side of Firm Lobbying: A Customer Perspective" and is authored by Gautham Vadakkepatt, Sandeep Arora, Kelly Martin, and Neeru Paharia.
A network of over 100 herbaria spread out across the southeastern United States recently completed the herculean task of fully digitizing more than three million specimens collected by botanists and naturalists over a span of 200 years. The project, which was funded by the National Science Foundation, is part of a larger, ongoing effort by natural history institutions worldwide to make their biological collections easily accessible to researchers studying broad patterns of evolution, extinction, range shifts, and climate change.
In a END ...
A team at the Natural History Museum (NHM), London is paving the way for future rovers to search for meteorites on Mars. The scientists are using the NHM's extensive meteorite collection to test the spectral instruments destined for the ExoMars rover Rosalind Franklin, and develop tools to identify meteorites on the surface of the red planet. The project is being presented today (23 July) at the virtual National Astronomy Meeting 2021.
The cratered surface of our nearest planetary neighbour has a long and complex history, and searching for rocks amidst more rocks may seem like a futile activity. Despite this, Martian rovers statistically have a significantly higher 'find per mile' success rate than dedicated meteorite hunts on ...
The first clinical trial of a new dietary treatment for children and adults with severe forms of epilepsy, co-developed by UCL researchers and based on the ketogenic diet, has been successfully completed.
For the study, published in Brain Communications, clinicians evaluated the use of K.Vita®, (also known as Betashot), an oral liquid dietary supplement developed by UCL in collaboration with Royal Holloway, University of London, and Vitaflo International Ltd.
The ketogenic diet (KD) consists of high-fat, low-carbohydrate and adequate protein consumption and mimics the fasting state, altering the metabolism to use body fat as the primary fuel source. This switch from carbohydrates to fat for body ...
A dust storm that engulfed Mars in 2018 destroyed a vortex of cold air around the planet's south pole and brought an early spring to the hemisphere. By contrast, the storm caused only minor distortions to the polar vortex in the northern hemisphere and no dramatic seasonal changes. Dr Paul Streeter of The Open University's Faculty of Science, Technology, Engineering and Mathematics will present the work today (23 July) at the virtual National Astronomy Meeting (NAM 2021).
Over two weeks at the beginning of June 2018, localised dust storms combined and spread to form an impenetrable blanket of dust that hid almost the entire planet's surface. The global dust storm, ...
CHAPEL HILL, North Carolina--Researchers at the UNC Lineberger Comprehensive Cancer Center demonstrated in a clinical trial in Malawi that a five-drug combination chemotherapy provided curative benefit compared to current standard-of care-therapy in people diagnosed with lymphoma, and now they have determined this option is also cost-effective. The economic finding appeared July 22, 2021, in Lancet Global Health.
The clinical trial results, reported May 19, 2021, in Lancet Global Health involved 37 people with diffuse large B-cell lymphoma (DLBCL). ...
CHAPEL HILL, North Carolina--A new study has demonstrated that patients with advanced bladder cancers whose tumors have a mutated FGFR3 gene respond to immunotherapy treatment in a manner that is similar to patients without that mutation, a discovery that runs counter to previous assumptions. This research, led by scientists at the University of North Carolina Lineberger Comprehensive Cancer Center, has important implications for patients who have not been offered immunotherapy because of their genetic profiles.
The findings are published in the British Journal of Cancer.
The National Cancer Institute estimates that 83,730 people in the United States will be diagnosed with bladder cancer in 2021, and the disease will cause 17,200 deaths. While the cancer ...
ROCHESTER, Minn. -- A new study by Fergus Couch, Ph.D., of Mayo Clinic Cancer Center, along with collaborators from the CARRIERS consortium, suggests that most women with breast cancer diagnosed over 65 should be offered hereditary cancer genetic testing. The study was published Thursday, July 22, in the Journal of Clinical Oncology.
Dr. Couch says that women over 65 rarely qualify for hereditary cancer genetic testing based on current testing guidelines because they are thought to exhibit low rates of genetic mutations in breast cancer genes.
"Most studies of breast cancer genes have not looked at older women, those who were diagnosed over the age of 65," says Dr. Couch. He says these studies have mainly tested women with a strong family history of breast ...
- Data show dose-responsive, non-saturated increases in gastrointestinal consumption of Phe in humans by SYNB1618 -
- SYNB1618 Phase 2 study in patients with PKU ongoing with proof-of-concept readout anticipated in 2H 2021 -
- Phase 1 study of SYNB1934, an evolved strain of SYNB1618 in the PKU portfolio, initiated -
CAMBRIDGE, Mass., July 22, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced today the publication of two papers in the journals Nature Metabolism and Communications Biology. The publications detail findings ...
LAST 30 PRESS RELEASES:
[Press-News.org] Bacteria navigate on surfaces using a 'sense of touch'